Xavier Gonzalez
Instituto Oncológico Dr Rosell, Pangaea Oncology
Sant Cugat Del Valles, CT, Spain
Sant Cugat Del Valles, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain).
Journal: Current problems in cancer
Published: June 26, 2026
Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis.
Journal: Cancer treatment reviews
Published: October 05, 2025
Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Advanced Breast Cancer: Randomized Phase II, SOLTI-1303 PATRICIA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 05, 2025
Palbociclib, trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer: randomised phase II, SOLTI-1303 PATRICIA trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 05, 2025
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.
Journal: ESMO open
Published: June 16, 2025
Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results.
Journal: NPJ breast cancer
Published: March 27, 2025
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial.
Journal: EClinicalMedicine
Published: March 06, 2025
Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy.
Journal: NPJ breast cancer
Published: June 20, 2024
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
Journal: Cancers
Published: November 08, 2022
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Journal: Future oncology (London, England)
Published: October 06, 2022
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Journal: Cancer treatment reviews
Published: February 15, 2022
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.
Journal: Future oncology (London, England)
Published: July 08, 2020
Last Updated: 09/26/2026